When to cardioversion and when to modulate ventricular response. State of the art guidelines

Juan Alejandro Cordero Cabra

2004, Number s2

<< Back Next >>

Arch Cardiol Mex 2004; 74 (s2)

When to cardioversion and when to modulate ventricular response. State of the art guidelines

Cordero CJA

Full text

How to cite this article

Language: Spanish
References: 10
Page: 298-301
PDF size: 46.16 Kb.

ABSTRACT

Atrial fibrilation is the cause of one third of hospital admission in cardiac arrythmias. Treatment success depends in measures such as: ventricular rhythm control, anticoagulation, use of beta-adrenergic blockers, and electric or pharmacological cardioversion.

REFERENCES

Benjamín EJ, Levy D, Vaziri SM, D´Angostino RB, Belanger AJ, Wolf PA: Independent risk factors for atrial fibrillation in a population-based cohort: The Framingham Heart Study. J Am Med Assoc 1994; 271: 840-4.
Chugh SS, Blackshear JL, Shen WK, Hammill SC, Gersh BJ, DPhill ChB: Epidemiology and Natural History of Atrial Fibrillation: Clinical Implications. J Am Coll Cardiol 2001; 37: 371-378.
Kowey PR, Gan-Xin Y, Winkel E, Kao W: Pharmacologic and nonpharmacologic options to Mantein Sinus Rhythm: Guideline-Based and New Approaches. Am J Cardiol 2003; 91(Suppl.): 33D-38D.
Petersen P, Gring M, Alder J: Ximelagatran Versus Warfarin for Strok Prevention in Patients With Nonvalvular Atrial Fibrillation. SPORTIF II. A Dose-Guiding, Tolerability, and Safety. J Am Coll Cardiol 2003; 41: 1445-1451.
Hohnloser SH, Kuck K-H, Lilienthal J. For the PIAF Investigators: Rhythm or rate control in atrial fibrillation-Pharmacologic Intervention in Atrial Fibrillation (PIAF): A Randomized trial. Lancet 2000; 356: 1789-1794.
Brignole M, Menozzi C, Gasparini M, Bongiorni MG, Botto GL, Ometto R, Alboni P, et al. For the PAF 2 Investigators: An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation. Eur Heart J 2002; 23: 892-900.
The AFFIRM Investigators: A Comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-1833.
Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ. For the RACE Investigators: A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002; 347: 1834-1840.
Carlsson J, Miketic S, Windeler J, Cuneo A, Haun S, Micus S, Walter S, Tebbe U, for the STAF Investigators: Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: STAF Trial. J Am Coll Cardiol 2003; 41: 1690-1696.
Klein AL, Grima RA, Murria RS, et al: Use os transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 2001; 344: 1411-1420.